FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

35655811000001103: Dinutuximab beta 20mg/4.5ml solution for infusion vials 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Sep 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
109491301000001119 Dinutuximab beta 20mg/4.5ml solution for infusion vials 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
109491401000001110 Dinutuximab beta 20mg/4.5ml solution for infusion vials 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dinutuximab beta 20mg/4.5ml solution for infusion vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dinutuximab beta 20mg/4.5ml solution for infusion vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Dinutuximab beta 20mg/4.5ml solution for infusion vials 1 vial Has VMP Dinutuximab beta 20mg/4.5ml solution for infusion vials true Inferred relationship Existential restriction modifier
Dinutuximab beta 20mg/4.5ml solution for infusion vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dinutuximab beta 20mg/4.5ml solution for infusion vials 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dinutuximab beta 20mg/4.5ml solution for infusion vials 1 vial Has specific active ingredient Dinutuximab beta true Inferred relationship Existential restriction modifier
Dinutuximab beta 20mg/4.5ml solution for infusion vials 1 vial Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Qarziba 20mg/4.5ml concentrate for solution for infusion vials (EUSA Pharma (UK) Ltd) 1 vial Is a True Dinutuximab beta 20mg/4.5ml solution for infusion vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start